Head-to-head comparison
DrMedHealth vs Hers
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
DrMedHealth is a LegitScript-certified US telehealth platform for GLP-1 medical weight loss.
From $199/mo (lowest dose rung) sema · From $299/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Compounded GLP-1s are not FDA-approved for safety, efficacy or quality
FDAWarning letter issued to Public Health Solution LLC dba DrMedHealth in June 2026. See the FDA warning-letter database.
Desk Score
Women-focused telehealth brand from Hims and Hers offering compounded semaglutide on a 6-month plan.
From $199/mo (lowest dose rung) sema · $299/mo (brand-name) tirz · Verified July 2026
Marked down on: Limited public information on program details
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.
Hers takes this head-to-head with the higher Desk Score, 76/100 (C) against 65/100 (C) for DrMedHealth. DrMedHealth still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
DrMedHealth
65/100
C
Hers
76/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | DrMedHealth | Hers |
|---|---|---|
| Semaglutide | From $199/molowest dose rung$199/mo (starting dose, compounded) | From $199/molowest dose rung$199/mo (starting dose, compounded) |
| Tirzepatide | From $299/molowest dose rung$299/mo (starting dose, compounded) | $299/mobrand-name$299/mo (starting dose, plus a separate fee, brand-name) |
| Coverage | Not listed on DrMedHealth's site (checked July 2026) | All 50 states |
| Brand-name | Yes | Yes |
| Oral option | Injectable only | Injectable only |
| Best for | Cost-conscious patients seeking low-priced compounded GLP-1s from a LegitScript-certified clinic. | Mainstream telehealth GLP-1 access. |
| Desk Score | 65/100C | 76/100C |
The verdict
Desk pick — HersHers takes this head-to-head with the higher Desk Score, 76/100 (C) against 65/100 (C) for DrMedHealth. DrMedHealth still holds its ground where its strengths line up with yours.
Choose DrMedHealth if…
Cost-conscious patients seeking low-priced compounded GLP-1s from a LegitScript-certified clinic.
From $199/mo (lowest dose rung) sema · From $299/mo (lowest dose rung) tirz
FDAWarning letter issued to Public Health Solution LLC dba DrMedHealth in June 2026. See the FDA warning-letter database.
Choose Hers if…
Mainstream telehealth GLP-1 access.
From $199/mo (lowest dose rung) sema · $299/mo (brand-name) tirz · All 50 states
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hers in September 2025. See the FDA warning-letter database.
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: DrMedHealth · Hers.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs DrMedHealth
- CoreAge Rx vs Hers
- DrMedHealth vs Eden
- Eden vs Hers
- DrMedHealth vs Pallas Health
- Hers vs Pallas Health
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.